Deep integration of proven AI tools into Philips cardiovascular ultrasound systems to better diagnose more cardiac disease patients

Philips celebrates 1.9m liters of helium saved as it marks 1,111 helium-free MRI operations installs, expanding care to more patients in more locations

Philips successfully prices offering of Notes for EUR 700 million to be used for repayment of existing debt

Philips ePatch and AI analytics platform rolled out to 14 hospitals across Spain to monitor heart patients

Philips Foundation 2023 Annual Report: unlocking quality medical services for over 28 million people in underserved communities

Amplexd Therapeutics, Innovating to Revolutionize the Future of Non-Invasive HPV-induced Cervical Intraepithelial Neoplasia (CIN) Treatments for the Prevention of Cervical Cancer: Developed by Women for Women

[img]http://phpstack-1214942-4313335.cloudwaysapps.com/api/ImageRender/DownloadFile?resourceId=f83bbfc7-6e0b-45d2-9685-2

Philips announces exchange ratio for 2023 dividend

Philips shareholders approve all proposals at the AGM 2024

Philips delivers first-quarter results in line with 2024 performance improvement plan; Resolves the Respironics personal injury and medical monitoring litigation in the US for USD 1.1 billion

Philips Respironics reaches agreement with US government on a consent decree creating a clear path forward

Philips convenes the Annual General Meeting of Shareholders 2024

Leading in health technology innovation: Philips one of the top patent applicants at European Patent Office